Which listed medication fails to have approval for weight management due to low efficacy?

Prepare for the MTM Pediatric Obesity Test with our comprehensive study aids. Use flashcards and multiple choice questions, each with detailed explanations and hints. Ensure you're ready for the exam!

Multiple Choice

Which listed medication fails to have approval for weight management due to low efficacy?

Explanation:
Weight management drugs are approved only when trials show a meaningful amount of weight loss beyond placebo. Lisdexamfetamine has not demonstrated sufficient efficacy for obesity treatment in those trials, so it does not have FDA approval for weight management. The other medications have shown approved benefits for weight loss: orlistat reduces fat absorption with modest weight loss, phentermine is approved for short-term use in adults as an appetite suppressant, and liraglutide (at the higher obesity-dose) has demonstrated meaningful weight loss and is approved for obesity in adults and certain adolescents. So, the medication without approval for weight management due to insufficient efficacy is lisdexamfetamine.

Weight management drugs are approved only when trials show a meaningful amount of weight loss beyond placebo. Lisdexamfetamine has not demonstrated sufficient efficacy for obesity treatment in those trials, so it does not have FDA approval for weight management. The other medications have shown approved benefits for weight loss: orlistat reduces fat absorption with modest weight loss, phentermine is approved for short-term use in adults as an appetite suppressant, and liraglutide (at the higher obesity-dose) has demonstrated meaningful weight loss and is approved for obesity in adults and certain adolescents. So, the medication without approval for weight management due to insufficient efficacy is lisdexamfetamine.

Subscribe

Get the latest from Examzify

You can unsubscribe at any time. Read our privacy policy